Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

March 20, 2026

Study Completion Date

September 20, 2026

Conditions
ChemsexAddictionInfectionsSexual Disorder, Physiological
Interventions
OTHER

Reinforced Communautary Support Program (PARC)

"Participants will complete the initial self-questionnaire collecting baseline socio-demographic, clinical characteristics, and all intermediate effectiveness outcome criteria \"before\". Concurrently with their participation in the program, they will complete various intermediate effectiveness evaluation questionnaires (\"after\") at 3 months (end of PARC) and 6 months (Post-PARC). Healthcare professionals running the PARC program will also complete questionnaires related to implementation indicators throughout the patients\' course (Adoption, Implementation, Maintenance).~Qualitative interviews will be conducted with patients and relevant healthcare professionals to explore barriers and drivers to the optimal deployment of the PARC program and to examine each of the Reach, Adoption, Implementation, Maintenance indicators through an organizational approach"

Trial Locations (1)

75011

Le 190 - Centre de Santé Sexuelle / CeGIDD, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06610916 - Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex | Biotech Hunter | Biotech Hunter